Subject: part 2 of CNV and Anti-VEGF Therapy Paper Discussed: Michels S, Rosenfeld PJ, Puliafito CA, et al. Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study. Ophthalmology, June 2005, 112(6) p1035-47 Guest: Philip J. Rosenfeld, M.D., Ph.D. Associate Professor of Ophthalmology Bascom Palmer Eye Institute University of Miami Miller School of Medicine Miami, Florida
Direct download: 2005-09-04.mp3
Category: -- posted at: 7:02pm EDT



-->

Syndication

Categories

Archives

September 2019
S M T W T F S
     
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30